Posts tagged va

• Is Byetta the Next Rezulin or Avandia – Yet Another Promising Drug That Faces Demise Safety Issues

  Brenda Fulmer | November 19, 2008 1:16 PM | 0 CommentsWest Palm Beach, FL Category: FDA & Prescription Drugs
  

  Those of us who have personally seen the devastating impact of diabetes in our own lives and those of our loved ones are always looking for the next great drug that might provide hope to our...

• Chantix: Why the Rush?

  Armand Rossetti | November 16, 2008 3:43 PM | 2 CommentsWest Palm Beach, FL Category: Defective & Dangerous Products
  

  In May 2006, the Food and Drug Administration (FDA) approved Pfizer’s Chantix (varenicline tartrate), a smoking cessation drug. Reportedly under priority review, the FDA had cut the usual...

• Connecting the dots: Reasons why fluoroquinolones such as Levaquin destroy connective tissue matrices found in tendons all over the body

  Armand Rossetti | November 14, 2008 2:30 PM | 0 CommentsWest Palm Beach, FL Category: Defective & Dangerous Products
  

  Sometimes searching for information has to occur outside the box. For example, who would have thought that a scholarly paper about eye drops would contain information central to understanding how...

• The Floxacin Gang: Cipro, Levaquin, Factive, Cinobac, Tequin, Enoxacin, Grepafloxacin, Sparfloxacin, Temafloxacin, and Trovan

  Armand Rossetti | November 13, 2008 5:08 PM | 0 CommentsWest Palm Beach, FL Category: Defective & Dangerous Products
  

  Please watch the Fluoroquinolone Toxicity Research Foundation’s video entitled A Prescription for Disaster. Two drugs, Cipro and Levaquin, belonging to the fluoroquinolone (Floxacin)...

• Regranex: Opening a Tube of It is like Opening Pandora’s Box

  Armand Rossetti | November 12, 2008 9:49 AM | 0 CommentsWest Palm Beach, FL Category: Defective & Dangerous Products
  

  According to Sharon Bourke, et al., authors of a paper entitled, “A Photo-Cross-linked Poly(vinyl Alcohol) Hydrogel Growth Factor Release Vehicle for Wound Healing Applications” that...

• Hospitalizations Due to Heart Failure Increased 131%

  Sandy Grinnell | November 10, 2008 3:53 PM | 1 CommentOrlando, FL Category: Miscellaneous
  

  The number of seniors over 65 who were hospitalized due to heart failure increased 131% from 1980 to 2006 according to a study released at the American Heart Association (AHA) Scientific Session...

• Problems Abound for Brand-Name Drug Manufacturers; They May Now Be Liable for Injuries Due to Competitors’ Generic Versions of the Same Drug

  Armand Rossetti | November 10, 2008 11:20 AM | 0 CommentsWest Palm Beach, FL Category: Defective & Dangerous Products
  

  On November 7, 2008 San Francisco’s 1st District Court of Appeal ruled that original brand name drug makers can now be held liable for injuries that competing generic drug companies cause when...

• The FDA Transvaginal Surgical Mesh Placement Complications Notification: Manufacturer Identification, and MAUDE Report Breakdown by Device

  Armand Rossetti | November 06, 2008 11:50 AM | 0 CommentsWest Palm Beach, FL Category: Medical Devices & Implants
  

  On October 20, 2008, The FDA issued a dear healthcare practitioner notice, concerning complications associated with transvaginal placement of surgical mesh for certain procedures. The notification...

• Tension Free Vaginal Tape (TVT or Vaginal Sling): What is it and how is it placed?

  Armand Rossetti | November 06, 2008 8:41 AM | 0 CommentsWest Palm Beach, FL Category: Medical Devices & Implants
  

  Tension free vaginal tape (TVT) is a relatively narrow strip of propylene mesh tape [1.1 cm (1/2 inch) X 40 cm (14 inches)] with two stainless steel needles, one at each end that surgeons insert at...

• Byetta: A Story About FDA Approval, FDA Warnings, and Amylin & Lilly’s Quest to Build Shareholder Value; What about Preemption versus Patient Safety?

  Armand Rossetti | November 02, 2008 3:38 PM | 0 CommentsWest Palm Beach, FL Category: FDA & Prescription Drugs
  

  Byetta (exenatide) is an analogue of glucagon-like peptide (GLP-1) derived from the saliva of a Gila monster. Injected twice daily an hour before meals, the drug mimics GLP-1 and enhances insulin...